Goa to introduce pricing policy for innovative lifesaving therapies
State to be reportedly first in India to implement outcome-linked pricing for advanced treatments, beginning with lung cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Government of India to host Bharat NutraVerse Expo 2025
Government of India, through SHEFEXIL, to bring global nutraceutical leaders together in New Delhi from 4–6 September 2025 to…
Greenspace Herbs unveils Quantum Ayurveda technology platform
The business has mapped 25,000 bioactive signatures and is currently working on 150,000 more
Lilly launches Mounjaro KwikPen (tirzepatide) in India
The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare…
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquisition will be funded through the IPO proceeds raised by Senores. This is in line with the Objects of the IPO stated in…
Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20…
Rivaroxaban Tablets USP will be manufactured at the company’s facility located in Goa
Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide facility at…
Integrated with a pilot plant for early-stage synthesis and for non-GMP scale-up, the facility will add fit-for-purpose GMP…
Kantar study maps India’s health and wellness search trends for 2024
New report analyses 15 wellness categories to reveal changing consumer focus areas based on Google search patterns
Celcius Logistics launches Celcius+ to strengthen pharma cold supply chain in India
₹50 crore investment to build dedicated pharma fleet, infrastructure, and compliance-driven logistics solutions
Bionova Scientific launches Texas pDNA facility to expand cell and gene therapy capabilities
The Woodlands site to support research-grade and CGMP plasmid DNA production for advanced therapeutics by late 2025
The Saffron book: An orange book of India
Milind Sathe highlights the need for a publicly accessible Indian equivalent of the US FDA’s Orange Book, proposing a Saffron Book…
Lupin announces licensing deal for Ranibizumab biosimilar
Lupin will manufacture and file regulatory submissions, while Sandoz will commercialise the biosimilar across select global…
T-cell engagers to drive immuno-oncology next growth wave: GlobalData
Bispecific T-cell engagers forecast to expand from 10% to 35% of the global immuno-oncology market by 2031 as immune checkpoint…
U.S. Tariffs on India’s pharma: Who pays, what’s at risk
The structural answer to tariff risk is not endless cost-cutting; it is moving up the value chain
Pfizer launches Pneumococcal Conjugate Vaccine for adults in India
Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes including both invasive and…
Eyestem Research raises $10 million to advance Eyecyte-RPE cell therapy for dry AMD
Funding to support Phase 2 clinical trial in India and preparations for US FDA Investigational New Drug application
Zydus receives USFDA approval for Diltiazem Hydrochloride Tablets in multiple strengths
Approval covers 30 mg, 60 mg, 90 mg, and 120 mg tablets for the management of chronic stable angina and angina due to coronary…
AbbVie’s upadacitinib holds potential to cement dominant place in alopecia areata with latest…
Phase III UP-AA trial data show higher response rates than current JAK inhibitors, positioning AbbVie’s upadacitinib as a…
Lupin launches Glucagon for injection USP in the United States
Product indicated for severe hypoglycaemia treatment and as a diagnostic aid during radiologic procedures in adults
Can we reduce plastics usage in pharmaceutical industry? – Think
Dr Ashok Omray highlights the widespread use of single-use plastics in pharma manufacturing and calls for scientific solutions to…